Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Use of Escherichia coli Nissle 1917 producing recombinant colicins for treatment of IBD patients

7 May 2016

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Escherichia coli research studies
Share to Gut microbiota and health
Share to Viral gastroenteritis research and epidemiology

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 27372848
DOI: 10.1016/j.mehy.2016.05.002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Use of Escherichia coli Nissle 1917 producing recombinant colicins for treatment of IBD patientsPMID 27372848Read ↗

Construction of Probiotic Escherichia coli Nissle 1917 as a Next- Generation Expression Platform and Its Application in Therapeutic Protein ProductionSemantic proximity Read ↗

Engineering <i>Escherichia coli</i> Nissle as safe chassis for delivery of therapeutic peptidesSemantic proximity Read ↗

Bioengineered Escherichia coli Nissle 1917 Mitigates Intestinal Inflammation in a Porcine Model of DSS-induced ColitisSemantic proximity Read ↗

From probiotic chassis to modification strategies, control and improvement of genetically engineered probiotics for inflammatory bowel diseaseSemantic proximity Read ↗

A Toxic Friend: Genotoxic and Mutagenic Activity of the Probiotic Strain Escherichia coli Nissle 1917.Semantic proximity Read ↗

A toxic friend: Genotoxic and mutagenic activity of the probiotic strain <i>Escherichia coli</i> Nissle 1917Semantic proximity Read ↗

Engineered stable, antibiotic-free, high-level protein expression in the probiotic chassis Escherichia coli Nissle 1917Semantic proximity Read ↗

Isolation and characterisation of two novel coliphages with high potential to control antibiotic-resistant pathogenic Escherichia coli (EHEC and EPEC)Semantic proximity Read ↗

Engineering probiotic <i>Escherichia coli</i> Nissle 1917 to block transfer of multiple antibiotic resistance genes by exploiting a type I CRISPR-Cas systemSemantic proximity Read ↗

Engineering a novel probiotic toolkit in <i>Escherichia coli Nissle1917</i> for sensing and mitigating gut inflammatory diseasesSemantic proximity Read ↗

Modulation of natural immunity in the gut by Escherichia coli strain Nissle 1917Semantic proximity Read ↗

Escherichia coli as a glycoprotein production host: recent developments and challengesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.